UK markets close in 7 hours 46 minutes

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.9000+0.0300 (+1.60%)
At close: 04:00PM EDT
1.8200 -0.08 (-4.21%)
After hours: 07:01PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
9,165
7,189
40,750
13,954
Other short-term investments
4,087
15,862
0
-
Total cash
13,252
23,050
40,750
13,954
Net receivables
0
39.881
110.141
0
Other current assets
739.179
163.452
1,503
54.837
Total current assets
14,211
24,371
42,470
14,783
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
326.052
571.898
0
-
Accumulated depreciation
-30.453
-6.723
-
-
Net property, plant and equipment
295.599
565.175
0
-
Total non-current assets
295.599
565.175
0
0
Total assets
14,507
24,936
42,470
14,783
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
248.911
42.534
Accounts payable
646.767
1,151
1,090
1,721
Accrued liabilities
1,625
1,938
2,294
632.934
Deferred revenues
-
-
0
2,326
Total current liabilities
3,439
3,695
4,054
4,722
Non-current liabilities
Long-term debt
-
-
-
276.461
Total non-current liabilities
90.124
205.451
0
276.461
Total liabilities
3,529
3,901
4,054
4,998
Stockholders' equity
Common stock
6.186
4.224
25.155
10.051
Retained earnings
-66,901
-47,872
-29,818
-15,032
Accumulated other comprehensive income
0.877
104.718
0
-
Total stockholders' equity
10,978
21,035
38,416
9,784
Total liabilities and stockholders' equity
14,507
24,936
42,470
14,783